Abstract
Previous studies have shown that women of color are often underrepresented in clinical trials of antiretroviral therapy. Enrollment of nonrepresentative patient populations, as a result of either patient choice or provider selection, can bias study results and generate conclusions with limited applicability. To shed light on this issue, investigators evaluated rates and reasons for nonenrollment in a large prospective cohort study on interventions to prevent mother-to-child HIV transmission and to protect maternal health. Of …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
